Showing results (241-250 of 914) with videos related to
Sort By:
Pageof 92
Clinical Neuropharmacology|January 1, 1984
L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's diseaseD R Cooper, C Marrel, B Testa, et al.Annals of Neurology|December 1, 1994
Complex I, iron, and ferritin in Parkinson's disease substantia nigraV M Mann, J M Cooper, S E Daniel, et al.European Journal of Pharmacology|August 3, 1989
Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437P A Löschmann, P N Chong, M Nomoto, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Administration of MPTP to the common marmoset does not alter cortical cholinergic functionJ Garvey, M Petersen, C M Waters, et al.Biochemical Pharmacology|October 17, 1998
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's diseaseK S McNaught, P A Carrupt, C Altomare, et al.Nature|January 2, 1986
1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayA J Bradbury, B Costall, A M Domeney, et al.Brain Research|March 20, 1999
Expression and localisation of CYP2D enzymes in rat basal gangliaA G Riedl, P M Watts, R J Edwards, et al.Neuroreport|September 8, 1994
Nigral dopaminergic cell loss in vitamin E deficient ratsD T Dexter, I Nanayakkara, M A Goss-Sampson, et al.Journal of Neurochemistry|September 1, 1997
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigraZ I Alam, A Jenner, S E Daniel, et al.Neuroscience|January 9, 1999
Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylaseP M Watts, A G Riedl, D C Douek, et al.Pageof 92